Gain insights from provocative, frank and visionary panel discussions-no boring speeches or sales pitches!

Learn about the import and impact of the latest advancements in cancer research and treatments for patients, companies and payers

Access leading oncology innovators, industry executives and investors through Cancer Progress Partnering

Keynote Speakers

Engineering the Future: Next Gen Platforms in Oncology

Daniel S. Chen, MD, PhD

Chief Medical Officer
Tuesday, May 4, 2021 | 9:15 – 10:00 am EDT


Off-the-shelf CAR-engineered NK cells for the treatment of cancer
Katy Rezvani, MD, PhD
Sally Copper Murray Endowed Chair in Cancer ResearchProfessor of Medicine, Chief, Section of Cellular Therapy,Director for Translational Research Medical Director, SCT Laboratory and the GMP Laboratory, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center
Wednesday, May 5, 2021 | 9:15 – 10:00 am EDT
AGENDA | REGISTER (Early Bird: $299)